Brookside Mezzanine Partners has made an investment in Northwest Cosmetic Laboratories (NCL). Brookside Mezzanine Partners provided the subordinated debt along with an equity co-investment to support the acquisition of NCL by Clearview Capital.
NCL is a rapidly growing formulator and manufacturer of innovative skincare and cosmetic products for prestige branded cosmetic and personal care companies. The company was founded in 1995 and headquartered in Idaho Falls, ID (www.trustncl.com).
Clearview Capital is a leading middle-market private investment firm that invests exclusively alongside management in manufacturing and service companies with strong prospects for growth. Clearview’s Fund III will continue the same investment strategy of its two predecessor funds by providing subordinated debt and minority equity to small and mid-sized companies seeking capital to support buyouts, leveraged recapitalizations, strategic acquisitions, dividends and growth capital. Brookside will invest up to $20 million per transaction, with the resources to complete larger transactions as well.
Founded in 2001, Brookside Mezzanine Partners manages in excess of $500 million across three mezzanine funds. The firm is a provider of subordinated debt and minority equity capital to small and mid-sized companies throughout the United States. We invest in both sponsored and non-sponsored transactions and provide junior capital and unitranche financing to support buyouts, leveraged recapitalizations, strategic acquisitions, dividends and growth capital. Brookside will invest up to $20 million per transaction, with the resources to complete larger transactions as well. Brookside Mezzanine Partners was founded in 2001 and has offices in Stamford, CT and Boston, MA (www.brooksidemezzanine.com).
2014 PEPD • Private Equity’s Leading News Magazine • 6-9-14